Literature DB >> 7945327

Identification of the nucleolar targeting signal of human angiogenin.

J Moroianu1, J F Riordan.   

Abstract

Angiogenin is endocytosed by subconfluent endothelial cells, translocated to the nucleus and accumulates in the nucleolus. It also localizes into the nucleolus of digitonin-permeabilized endothelial cells. The peptide RRRGL corresponding to residues 31-35 of human angiogenin specifically targets non-nuclear carrier proteins such as albumin, an anti-human nucleolus monoclonal antibody and R33A angiogenin to the nucleolus of permeabilized endothelial cells. Proteins conjugated with a "mutant" peptide, RRAGL, are not imported. Fluorescein isothiocyanate-conjugated RRRGL is also rapidly imported into the nucleus and localized to the nucleolus, whereas the "mutant" peptide is not. Residue R33 is essential for nuclear translocation and R31 and R32 appear to modulate this process. Thus, 31RRRGL35 is a nuclear localization signal responsible for the nucleolar targeting of human angiogenin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945327     DOI: 10.1006/bbrc.1994.2391

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  42 in total

1.  Unique motif for nucleolar retention and nuclear export regulated by phosphorylation.

Authors:  Frédéric Catez; Monique Erard; Nathalie Schaerer-Uthurralt; Karine Kindbeiter; Jean-Jacques Madjar; Jean-Jacques Diaz
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 2.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

3.  Structure of murine angiogenin: features of the substrate- and cell-binding regions and prospects for inhibitor-binding studies.

Authors:  Daniel E Holloway; Gayatri B Chavali; Michelle C Hares; Vasanta Subramanian; K Ravi Acharya
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-11-19

Review 4.  Ribonuclease inhibitor: structure and function.

Authors:  Kimberly A Dickson; Marcia C Haigis; Ronald T Raines
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

5.  Angiogenin stimulates ribosomal RNA transcription by epigenetic activation of the ribosomal DNA promoter.

Authors:  Jinghao Sheng; Wenhao Yu; Xiangwei Gao; Zhengping Xu; Guo-Fu Hu
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

6.  Rare Angiogenin and Ribonuclease 4 variants associated with amyotrophic lateral sclerosis exhibit loss-of-function: a comprehensive in silico study.

Authors:  Aditya K Padhi; Priyam Narain; James Gomes
Journal:  Metab Brain Dis       Date:  2019-07-31       Impact factor: 3.584

7.  Angiogenin interacts with the plasminogen activation system at the cell surface of breast cancer cells to regulate plasmin formation and cell migration.

Authors:  Sujoy Dutta; Chirosree Bandyopadhyay; Virginie Bottero; Mohanan V Veettil; Lydia Wilson; Michael R Pins; Karen E Johnson; Case Warshall; Bala Chandran
Journal:  Mol Oncol       Date:  2014-01-04       Impact factor: 6.603

8.  Neomycin inhibits angiogenin-induced angiogenesis.

Authors:  G F Hu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

Review 9.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

10.  Mutational dynamics of murine angiogenin duplicates.

Authors:  Francisco M Codoñer; Silvia Alfonso-Loeches; Mario A Fares
Journal:  BMC Evol Biol       Date:  2010-10-15       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.